Scholar
Sort by
2 items
-
Business - MarketWatch
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy
The Phase 3 trial of apitegromab showed statistically significant improvement in motor function.7 hours ago